Guangchun Han, Ansam Sinjab, K. Hara, Warapen Treekitkarnmongkol, Patrick M Brennan, K. Chang, Elena Bokatenkova, B. Sánchez-Espiridión, C. Behrens, L. Solis, B. Gao, L. Girard, Jianjun Zhang, B. Sepesi, T. Cascone, L. Byers, D. Gibbons, Jichao Chen, S. Moghaddam, E. Ostrin, P. Scheet, J. Fujimoto, J. Shay, J. Heymach, J. Minna, S. Dubinett, I. Wistuba, Christopher S. Stevenson, A. Spira, Linghua Wang, H. Kadara
{"title":"Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptorACE2and host proteases in human lung adenocarcinoma","authors":"Guangchun Han, Ansam Sinjab, K. Hara, Warapen Treekitkarnmongkol, Patrick M Brennan, K. Chang, Elena Bokatenkova, B. Sánchez-Espiridión, C. Behrens, L. Solis, B. Gao, L. Girard, Jianjun Zhang, B. Sepesi, T. Cascone, L. Byers, D. Gibbons, Jichao Chen, S. Moghaddam, E. Ostrin, P. Scheet, J. Fujimoto, J. Shay, J. Heymach, J. Minna, S. Dubinett, I. Wistuba, Christopher S. Stevenson, A. Spira, Linghua Wang, H. Kadara","doi":"10.1158/1538-7445.AM2021-702","DOIUrl":null,"url":null,"abstract":"The novel coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic. Severely symptomatic COVID-19 is associated with lung inflammation, pneumonia, and respiratory failure, thereby raising concerns of elevated risk of COVID-19-asociated mortality among lung cancer patients. Angiotensin converting enzyme 2 (ACE2) is the major receptor for SARS-CoV-2 entry into lung cells. Yet, the single-cell expression landscape of ACE2 and other SARS-CoV-2-related genes in pulmonary tissues of lung cancer patients remains unknown. To fill these voids, we leveraged our ongoing efforts in single-cell transcriptomic analysis of 186,916 cells including a large number of epithelial cells (n=70,030) derived from 5 LUADs and 14 matching uninvolved normal lung tissues, to delineate expression levels and cellular distribution of ACE2 and SARS-CoV-2 priming proteases TMPRSS2 and TMPRSS4. Single-cell RNA sequencing of 186,916 cells revealed epithelial-specific expression of ACE2, TMPRSS2 and TMPRSS4. Analysis of 70,030 LUAD- and normal-derived epithelial cells showed that ACE2 levels were highest in normal alveolar type 2 (AT2) cells and that TMPRSS2 was expressed in 65% of normal AT2 cells. Conversely, expression of TMPRSS4 was highest and most frequently detected (75%) in malignant lung cells. ACE2-positive cells co-expressed genes implicated in lung pathobiology, including COPD-associated HHIP, and the scavengers CD36 and DMBT1. Notably, the viral scavenger DMBT1 was significantly positively correlated with ACE2 expression in AT2 cells. In conclusion, we describe normal and tumor lung epithelial populations that express SARS-CoV-2 receptor and proteases, as well as major host defense genes, and that thus comprise potential treatment targets for COVID-19 particularly among lung cancer patients. Citation Format: Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, Elena Bokatenkova, Beatriz Sanchez-Espiridion, Carmen Behrens, Luisa M. Solis, Boning Gao, Luc Girard, Jianjun Zhang, Boris Sepesi, Tina Cascone, Lauren A. Byers, Don L. Gibbons, Jichao Chen, Seyed Javad Moghaddam, Edwin J. Ostrin, Paul Scheet, Junya Fujimoto, Jerry Shay, John V. Heymach, John D. Minna, Steven Dubinett, Ignacio I. Wistuba, Christopher S. Stevenson, Avrum E. Spira, Linghua Wang, Humam Kadara. Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 702.","PeriodicalId":417728,"journal":{"name":"COVID-19 and Cancer","volume":"52 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"COVID-19 and Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.AM2021-702","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The novel coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic. Severely symptomatic COVID-19 is associated with lung inflammation, pneumonia, and respiratory failure, thereby raising concerns of elevated risk of COVID-19-asociated mortality among lung cancer patients. Angiotensin converting enzyme 2 (ACE2) is the major receptor for SARS-CoV-2 entry into lung cells. Yet, the single-cell expression landscape of ACE2 and other SARS-CoV-2-related genes in pulmonary tissues of lung cancer patients remains unknown. To fill these voids, we leveraged our ongoing efforts in single-cell transcriptomic analysis of 186,916 cells including a large number of epithelial cells (n=70,030) derived from 5 LUADs and 14 matching uninvolved normal lung tissues, to delineate expression levels and cellular distribution of ACE2 and SARS-CoV-2 priming proteases TMPRSS2 and TMPRSS4. Single-cell RNA sequencing of 186,916 cells revealed epithelial-specific expression of ACE2, TMPRSS2 and TMPRSS4. Analysis of 70,030 LUAD- and normal-derived epithelial cells showed that ACE2 levels were highest in normal alveolar type 2 (AT2) cells and that TMPRSS2 was expressed in 65% of normal AT2 cells. Conversely, expression of TMPRSS4 was highest and most frequently detected (75%) in malignant lung cells. ACE2-positive cells co-expressed genes implicated in lung pathobiology, including COPD-associated HHIP, and the scavengers CD36 and DMBT1. Notably, the viral scavenger DMBT1 was significantly positively correlated with ACE2 expression in AT2 cells. In conclusion, we describe normal and tumor lung epithelial populations that express SARS-CoV-2 receptor and proteases, as well as major host defense genes, and that thus comprise potential treatment targets for COVID-19 particularly among lung cancer patients. Citation Format: Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, Elena Bokatenkova, Beatriz Sanchez-Espiridion, Carmen Behrens, Luisa M. Solis, Boning Gao, Luc Girard, Jianjun Zhang, Boris Sepesi, Tina Cascone, Lauren A. Byers, Don L. Gibbons, Jichao Chen, Seyed Javad Moghaddam, Edwin J. Ostrin, Paul Scheet, Junya Fujimoto, Jerry Shay, John V. Heymach, John D. Minna, Steven Dubinett, Ignacio I. Wistuba, Christopher S. Stevenson, Avrum E. Spira, Linghua Wang, Humam Kadara. Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 702.
新型冠状病毒SARS-CoV-2是COVID-19大流行的病原体。有严重症状的COVID-19与肺部炎症、肺炎和呼吸衰竭有关,因此人们担心肺癌患者与COVID-19相关的死亡风险会增加。血管紧张素转换酶2 (ACE2)是SARS-CoV-2进入肺细胞的主要受体。然而,ACE2等sars - cov -2相关基因在肺癌患者肺组织中的单细胞表达格局尚不清楚。为了填补这些空白,我们利用我们正在进行的186,916个细胞的单细胞转录组学分析,包括来自5个luad和14个匹配的未参与正常肺组织的大量上皮细胞(n= 7030),以描绘ACE2和SARS-CoV-2引物蛋白酶TMPRSS2和TMPRSS4的表达水平和细胞分布。186,916个细胞的单细胞RNA测序显示ACE2、TMPRSS2和TMPRSS4的上皮特异性表达。对70,030个LUAD和正常来源的上皮细胞的分析显示,ACE2水平在正常肺泡2型(AT2)细胞中最高,TMPRSS2在65%的正常AT2细胞中表达。相反,TMPRSS4在恶性肺细胞中表达最高且最频繁(75%)。ace2阳性细胞共表达与肺病理生物学相关的基因,包括copd相关的hip,以及清道夫CD36和DMBT1。值得注意的是,病毒清道夫DMBT1与AT2细胞中ACE2的表达显著正相关。总之,我们描述了表达SARS-CoV-2受体和蛋白酶以及主要宿主防御基因的正常和肿瘤肺上皮群体,从而构成了COVID-19特别是肺癌患者的潜在治疗靶点。引文格式:韩光春、Ansam Sinjab、Kieko Hara、warrum E. Treekitkarnmongkol、Patrick Brennan、Kyle Chang、Elena Bokatenkova、Beatriz Sanchez-Espiridion、Carmen Behrens、Luisa M. Solis、Boning Gao、Luc Girard、Jianjun Zhang、Boris Sepesi、Tina Cascone、Lauren A. Byers、Don L. Gibbons、陈吉超、Seyed Javad Moghaddam、Edwin J. Ostrin、Paul Scheet、Junya Fujimoto、Jerry Shay、John V. Heymach、John D. Minna、Steven Dubinett、Ignacio I. Wistuba、Christopher S. Stevenson、Avrum E. Spira、王linghua、Kadara。SARS-CoV-2受体ACE2和宿主蛋白酶在人肺腺癌中的单细胞表达格局[摘要]。见:美国癌症研究协会2021年年会论文集;2021年4月10日至15日和5月17日至21日。费城(PA): AACR;癌症杂志,2021;81(13 -增刊):摘要第702期。